2009 Biopharma Deals Of The Year: Roche/Genentech, Movetis' IPO, Elan/J&J

Competition run by the IN VIVO Blog finds the most voter interest in the M&A/Alliances category, where Elan and J&J's Alzheimer's deal got the top prize.

More from Archive

More from Pink Sheet